Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Celcuity, Inc. stock logo
CELC
Celcuity
$45.88
+3.7%
$18.60
$7.57
$48.00
$1.79B0.682.58 million shs1.33 million shs
LifeMD, Inc. stock logo
LFMD
LifeMD
$6.82
+3.2%
$11.86
$3.99
$15.84
$323.38M1.722.21 million shs2.89 million shs
LifeStance Health Group, Inc. stock logo
LFST
LifeStance Health Group
$4.37
+13.2%
$4.77
$3.74
$8.61
$1.70B1.132.47 million shs7.39 million shs
PACS Group, Inc. stock logo
PACS
PACS Group
$11.15
+0.5%
$11.83
$8.28
$43.92
$1.70B0.88509,999 shs346,696 shs
7 AI Stocks to Invest in Today: Capitalizing on AI and Tech Trends in 2025 Cover

Discover the top 7 AI stocks to invest in right now. This exclusive report highlights the companies leading the AI revolution and shaping the future of technology in 2025.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Celcuity, Inc. stock logo
CELC
Celcuity
0.00%+14.96%+236.86%+352.02%+185.86%
LifeMD, Inc. stock logo
LFMD
LifeMD
0.00%-31.39%-42.98%-17.43%+27.00%
LifeStance Health Group, Inc. stock logo
LFST
LifeStance Health Group
0.00%+15.30%-7.61%-23.73%-20.69%
PACS Group, Inc. stock logo
PACS
PACS Group
0.00%+4.99%-12.82%+6.60%-65.69%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Celcuity, Inc. stock logo
CELC
Celcuity
0.7845 of 5 stars
1.51.00.00.02.33.30.0
LifeMD, Inc. stock logo
LFMD
LifeMD
2.5086 of 5 stars
3.52.00.00.02.81.70.6
LifeStance Health Group, Inc. stock logo
LFST
LifeStance Health Group
3.1914 of 5 stars
3.44.00.00.02.62.50.6
PACS Group, Inc. stock logo
PACS
PACS Group
3.1372 of 5 stars
3.43.00.00.01.40.01.9
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Celcuity, Inc. stock logo
CELC
Celcuity
3.00
Buy$39.20-14.56% Downside
LifeMD, Inc. stock logo
LFMD
LifeMD
3.00
Buy$12.8688.52% Upside
LifeStance Health Group, Inc. stock logo
LFST
LifeStance Health Group
2.86
Moderate Buy$8.5094.51% Upside
PACS Group, Inc. stock logo
PACS
PACS Group
2.86
Moderate Buy$34.29207.50% Upside

Current Analyst Ratings Breakdown

Latest LFMD, PACS, CELC, and LFST Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
8/8/2025
LifeStance Health Group, Inc. stock logo
LFST
LifeStance Health Group
UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$8.50 ➝ $9.00
8/7/2025
LifeMD, Inc. stock logo
LFMD
LifeMD
HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$14.00 ➝ $13.00
8/6/2025
LifeMD, Inc. stock logo
LFMD
LifeMD
Lake Street Capital
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$18.00 ➝ $14.00
8/6/2025
LifeMD, Inc. stock logo
LFMD
LifeMD
KeyCorp
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOverweight ➝ Overweight$14.00 ➝ $12.00
7/28/2025
Celcuity, Inc. stock logo
CELC
Celcuity
Leerink Partners
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOutperform ➝ Outperform$28.00 ➝ $60.00
7/28/2025
Celcuity, Inc. stock logo
CELC
Celcuity
HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$27.00 ➝ $50.00
7/28/2025
Celcuity, Inc. stock logo
CELC
Celcuity
Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$29.00
7/25/2025
LifeStance Health Group, Inc. stock logo
LFST
LifeStance Health Group
BTIG Research
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageBuy$8.00
7/14/2025
LifeMD, Inc. stock logo
LFMD
LifeMD
KeyCorp
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOverweight ➝ Overweight$12.00 ➝ $14.00
7/10/2025
LifeMD, Inc. stock logo
LFMD
LifeMD
Lake Street Capital
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$12.00 ➝ $18.00
7/1/2025
Celcuity, Inc. stock logo
CELC
Celcuity
Stifel Nicolaus
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageBuy$30.00
(Data available from 8/10/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Celcuity, Inc. stock logo
CELC
Celcuity
N/AN/AN/AN/A$3.11 per shareN/A
LifeMD, Inc. stock logo
LFMD
LifeMD
$212.45M1.52N/AN/A$0.01 per share682.00
LifeStance Health Group, Inc. stock logo
LFST
LifeStance Health Group
$1.25B1.36$0.04 per share110.21$3.78 per share1.16
PACS Group, Inc. stock logo
PACS
PACS Group
$3.56B0.48N/AN/AN/A
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Celcuity, Inc. stock logo
CELC
Celcuity
-$111.78M-$3.03N/AN/AN/AN/A-96.21%-49.44%8/14/2025 (Estimated)
LifeMD, Inc. stock logo
LFMD
LifeMD
-$18.88M-$0.21N/A56.83N/A-2.41%N/A-8.11%N/A
LifeStance Health Group, Inc. stock logo
LFST
LifeStance Health Group
-$57.44M-$0.10N/AN/AN/A-1.23%-1.12%-0.77%N/A
PACS Group, Inc. stock logo
PACS
PACS Group
$112.87MN/A0.006.26N/AN/AN/AN/A8/11/2025 (Estimated)

Latest LFMD, PACS, CELC, and LFST Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
8/14/2025Q2 2025
Celcuity, Inc. stock logo
CELC
Celcuity
-$0.94N/AN/AN/AN/AN/A
8/11/2025Q2 2025
PACS Group, Inc. stock logo
PACS
PACS Group
$0.45N/AN/AN/AN/AN/A
8/7/2025Q2 2025
LifeStance Health Group, Inc. stock logo
LFST
LifeStance Health Group
-$0.03-$0.01+$0.02-$0.01$345.05 million$345.31 million
5/14/2025Q1 2025
Celcuity, Inc. stock logo
CELC
Celcuity
-$0.95-$0.86+$0.09-$0.86N/AN/A
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Celcuity, Inc. stock logo
CELC
Celcuity
N/AN/AN/AN/AN/A
LifeMD, Inc. stock logo
LFMD
LifeMD
N/AN/AN/AN/AN/A
LifeStance Health Group, Inc. stock logo
LFST
LifeStance Health Group
N/AN/AN/AN/AN/A
PACS Group, Inc. stock logo
PACS
PACS Group
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Celcuity, Inc. stock logo
CELC
Celcuity
1.14
6.61
6.61
LifeMD, Inc. stock logo
LFMD
LifeMD
9.21
0.77
0.77
LifeStance Health Group, Inc. stock logo
LFST
LifeStance Health Group
0.19
1.47
1.47
PACS Group, Inc. stock logo
PACS
PACS Group
N/AN/AN/A

Institutional Ownership

CompanyInstitutional Ownership
Celcuity, Inc. stock logo
CELC
Celcuity
63.33%
LifeMD, Inc. stock logo
LFMD
LifeMD
35.52%
LifeStance Health Group, Inc. stock logo
LFST
LifeStance Health Group
85.50%
PACS Group, Inc. stock logo
PACS
PACS Group
N/A

Insider Ownership

CompanyInsider Ownership
Celcuity, Inc. stock logo
CELC
Celcuity
15.77%
LifeMD, Inc. stock logo
LFMD
LifeMD
18.40%
LifeStance Health Group, Inc. stock logo
LFST
LifeStance Health Group
3.20%
PACS Group, Inc. stock logo
PACS
PACS Group
N/A
CompanyEmployeesShares OutstandingFree FloatOptionable
Celcuity, Inc. stock logo
CELC
Celcuity
4038.91 million32.78 millionOptionable
LifeMD, Inc. stock logo
LFMD
LifeMD
23047.42 million38.69 millionOptionable
LifeStance Health Group, Inc. stock logo
LFST
LifeStance Health Group
10,218388.88 million376.43 millionOptionable
PACS Group, Inc. stock logo
PACS
PACS Group
32,433152.40 millionN/AOptionable

Recent News About These Companies

PACS Group (PACS) to Release Earnings on Monday
Unprecedented Big Money Surge for Super PAC Tied to Trump

New MarketBeat Followers Over Time

Media Sentiment Over Time

Celcuity stock logo

Celcuity NASDAQ:CELC

$45.88 +1.64 (+3.71%)
Closing price 08/8/2025 04:00 PM Eastern
Extended Trading
$46.78 +0.90 (+1.96%)
As of 08/8/2025 07:40 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Celcuity Inc., a clinical stage biotechnology company, focuses on the development of targeted therapies for the treatment of various solid tumors in the United States. The company's CELsignia diagnostic platform uses a patient's living tumor cells to identify the specific abnormal cellular process driving a patient's cancer and the related targeted therapy for the treatment. Its drug candidate includes Gedatolisib, which selectively targets various class I isoforms of PI3K and mammalian target of rapamycin and focus on the treatment of patients with hormone receptor positive, HER2-negative, advanced or metastatic breast cancer, and metastatic castration resistant prostate cancer. It had a license agreement with Pfizer, Inc. for the development and commercialization rights to Gedatolisib. The company was founded in 2011 and is headquartered in Minneapolis, Minnesota.

LifeMD stock logo

LifeMD NASDAQ:LFMD

$6.82 +0.21 (+3.18%)
Closing price 08/8/2025 04:00 PM Eastern
Extended Trading
$6.91 +0.09 (+1.30%)
As of 08/8/2025 07:57 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

LifeMD, Inc. operates as a direct-to-patient telehealth company that connects consumers to healthcare professionals for medical care in the United States. The company offers telehealth platform comprising RexMD, a men's telehealth brand that provides access to virtual medical treatment for a variety of men's health needs from licensed physician; ShapiroMD that provides virtual medical treatment, prescription medications, patented doctor formulated OTC products, topical compounded medications, and medical devices treating male and female hair loss; NavaMD, a female-oriented tele-dermatology that offers virtual medical treatment from dermatologists and other providers; and prescription oral and compounded topical medications to treat aging and acne; and Cleared which provides personalized treatments for allergy, asthma and immunology, including in-home tests for both environmental and food allergies, prescriptions for allergies and asthma and immunotherapies for treating chronic allergies. It also provides LifeMD PC, a direct-to-consumer virtual primary care which includes 24/7 access to a provider for their primary care, urgent care, and chronic care needs; and offers virtual consultations and treatment, prescription medications, diagnostics and imaging, wellness coaching, and more. In addition, the company offers PDFSimpli, an online software as a service platform that allows users to create, edit, convert, sign, and share PDF documents; ResumeBuild which provides digital resume and cover letter services; SignSimpli, a digital signature platform; and LegalSimpli, a provider of legal forms for consumers and small businesses. It sells its products directly to consumers and through e-commerce platforms, as well as through third party partner channels. The company was formerly known as Conversion Labs, Inc. and changed its name to LifeMD, Inc. in February 2021. LifeMD, Inc. was incorporated in 1994 and is headquartered in New York, New York.

LifeStance Health Group stock logo

LifeStance Health Group NASDAQ:LFST

$4.37 +0.51 (+13.21%)
Closing price 08/8/2025 04:00 PM Eastern
Extended Trading
$4.36 0.00 (-0.11%)
As of 08/8/2025 07:29 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

LifeStance Health Group, Inc., through its subsidiaries, provides outpatient mental health services to children, adolescents, adults, and geriatrics in the United States. The company offers patients a suite of mental health services, including psychiatric evaluations and treatment, psychological, and neuropsychological testing, as well as individual, family, and group therapy. It treats a range of mental health conditions, including anxiety, depression, bipolar disorder, eating disorders, psychotic disorders, and post-traumatic stress disorder. In addition, the company operates an outpatient mental health platform, as well as offers patient care virtually through its online delivery platform or in-person at its centers. LifeStance Health Group, Inc. was founded in 2017 and is headquartered in Scottsdale, Arizona.

PACS Group stock logo

PACS Group NYSE:PACS

$11.15 +0.06 (+0.54%)
Closing price 08/8/2025 03:59 PM Eastern
Extended Trading
$11.10 -0.05 (-0.45%)
As of 08/8/2025 06:35 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

PACS Group, Inc., through its subsidiaries, operates skilled nursing facilities and assisted living facilities in the United States. The company also provides senior care and independent facilities. It engages in the acquisition, ownership, and leasing of health care-related properties. The company was founded in 2013 and is based in Farmington, Utah.